Impinj executive sells over $120k in company stock

Published 25/09/2024, 22:50
© Reuters.

Impinj Inc's (NASDAQ:PI) Chief Revenue Officer, Jeffrey Dossett, recently sold a portion of his company stock, according to a new SEC filing. The transactions, which took place on September 24, 2024, involved the sale of 577 shares at prices ranging between $208.38 and $210.22, resulting in a total value of over $120,705.

The sale came after Dossett exercised options to acquire a total of 1,467 shares of common stock at no cost on September 23. Following these transactions, Dossett's direct ownership in the company stands at 64,532 shares of common stock. These moves are part of the normal course of action for company executives managing their personal stock holdings and often involve selling shares to cover tax obligations related to the vesting of restricted stock units (RSUs).

It should be noted that as part of the standard process, Dossett has committed to providing full details of the individual sales prices upon request, as indicated in the footnotes of the SEC filing. The reported sales were executed in multiple transactions to cover tax withholding obligations as RSUs settled, a common practice among executives receiving equity-based compensation.

Investors and followers of Impinj Inc. should be aware that such filings are routine and provide transparency regarding the stock transactions of company insiders. These disclosures are part of the regulatory framework designed to ensure fair and open markets.


In other recent news, Impinj Inc. reported strong second quarter financial results, with revenue surpassing $100 million and adjusted EBITDA exceeding $25 million. The company's performance was fueled by significant growth in various sectors, including apparel, footwear, retail, general merchandise, and specialty applications. Impinj projects a 42% year-over-year increase in product revenue for the third quarter.

Lake Street Capital Markets maintained a Buy rating on Impinj shares and increased its price target to $190 from the previous $155. Similarly, Evercore ISI increased its price target for Impinj shares to $205.00, up from the previous target of $172.00, following the company's announcement of a second quarter earnings per share beat by 12% and a third quarter EPS forecast increase of 21%.

Impinj has also announced key leadership changes, with Gahan Richardson becoming the Executive Vice President for products and platform and Alberto Pesavento assuming the role of CTO. The company is ramping up wafer orders to meet growing product demand. These recent developments underscore Impinj's confidence in its market position and long-term margin targets.


InvestingPro Insights


In light of the recent transactions by Impinj Inc's (NASDAQ:PI) Chief Revenue Officer, Jeffrey Dossett, investors might find the following InvestingPro data and tips useful for making informed decisions about the company's stock.

As of the last twelve months up to Q2 2024, Impinj Inc has a market capitalization of $6 billion. Despite a slight decline in revenue growth of -0.56%, the company's quarterly revenue growth shows a more positive figure at 19.2%. This indicates a potential for recovery and growth in the company's financial performance. The stock has been performing robustly with a one-year price total return of 288.3%, reflecting a strong market confidence in Impinj Inc.

InvestingPro Tips suggest that Impinj Inc's net income is expected to grow this year, which could be a positive signal for potential investors. Additionally, the fact that 7 analysts have revised their earnings upwards for the upcoming period further supports the optimistic outlook for the company. However, with a P/E Ratio of 479.74, the stock is trading at a high earnings multiple, which might indicate that it is priced optimistically relative to its earnings.

For those interested in a deeper analysis, there are additional InvestingPro Tips available on the platform (https://www.investing.com/pro/PI), which could provide further insights into Impinj Inc's financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.